SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (13081)8/11/1998 8:02:00 PM
From: VLAD  Read Replies (3) | Respond to of 23519
 
Another point discussed with Vivus.

8)Alibra will be a one dose product. Vivus feels that many patients were initially lost to MUSE because doctor's were starting titrations at the lowest dose and never successfully finishing titration at the highest and most common dose (now they know better and doctors are instructed to start titration at 500ucgs).